Sun Pharmaceutical Industries Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 6,83,246 shares,. Its Average Traded Price (ATP) is ₹1849.48, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1852.20.
Sun Pharmaceutical Industries has an upper circuit limit of ₹2037.40 and a lower circuit limit of ₹1667.00. The total value traded stands at ₹126.36 CR, and the delivery percentage for the day is 62.58%.
The stock is currently traded with a market lot size of 1. Sun Pharmaceutical Industries also offers a dividend yield of 0.86%.
Sun Pharmaceutical Industries Share Price Chart
Sun Pharmaceutical Industries Share Key Metrics
Volume
6.83 L
Market Cap
444404.82 CR
LTQ@LTP
1@1852.20
ATP
1849.48
Var Margin
12.5 %
Circuit Range
1667-2037.4
Delivery %
62.58 %
Value
126.36 CR
ASM/GSM
No
Market Lot
1
Sun Pharmaceutical Industries Resistance and Support
Pivot 1859.43
Resistance
First Resistance
1870.46
Second Resistance
1891.03
Third Resistance
1902.06
Support
First Support
1838.86
Second Support
1827.83
Third Support
1807.26
Sun Pharmaceutical Industries Futures & Options
1852.2
2.3 (0.12%)
Sun Pharmaceutical Industries Option Chain
View Price, OI, Greeks & More...
29SEP26
1856.00
3.10 (0.17%)
27OCT26
1865.30
2.70 (0.14%)
23NOV26
1875.60
5.70 (0.30%)
SUNPHARMA|29SEP26 CE 1840.00
18.60
-1.45 (-7.23%)
SUNPHARMA|29SEP26 PE 1860.00
13.6
-3.3 (-19.53%)
Sun Pharmaceutical Industries Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Sun Pharmaceutical Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-01-31 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results & Interim Dividend |
| 2024-10-28 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-07 | 2026-07-07 | View More |
Sun Pharmaceutical Industries News
Sun Pharmaceutical Industries Ltd - 524715 - Receipt Of Approval Of The Shareholders For Reclassification Of Shareholder Category
Sun Pharmaceutical shareholders approved the reclassification of individuals previously classified under the Promoter Group to the Public category. This reclassification, effective September 26, 2026, was done in accordance with SEBI Regulation 31A.
Sep 26 2026 22:17:51
Sun Pharmaceutical Industries Ltd - 524715 - Incorporation Of A Subsidiary Company
Sun Pharmaceutical has incorporated "Sun Pharma Global Treasury Centre IFSC Limited" as an indirect wholly-owned subsidiary in GIFT City on September 08, 2026. This new entity will manage the group's global treasury, funding, liquidity, and cash management activities.
Sep 09 2026 14:58:43
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharmaceutical participated in a White House ceremony, announcing agreements with the US government focused on medicine pricing and patient access. The agreements include extending Most Favored Nation (MFN) pricing to state Medicaid and delaying Section 232 tariffs on innovative pharma products for over two years.
Sep 01 2026 01:49:51
Sun Pharmaceutical Industries Management
| Name | Position |
|---|---|
| Anoop Deshpande | Company Secretary & Compliance Officer |
| Dilip S Shanghvi | Chairman & Managing Director |
Sun Pharmaceutical Industries Similar Stocks
Divi's Laboratories Ltd.
9619.50
17.50 (0.18%)
Torrent Pharmaceuticals Ltd.
4988.50
60.00 (1.22%)
Apollo Hospitals Enterprise Ltd.
8889.00
0.50 (0.01%)
Lenskart Solutions Ltd.
680.25
4.25 (0.63%)
Zydus Lifesciences Ltd.
1203.90
23.60 (2.00%)
Cipla Ltd.
1399.70
0.70 (0.05%)
Laurus Labs Ltd.
2007.00
-19.20 (0.95%)
Max Healthcare Institute Ltd.
1014.00
-32.00 (3.06%)
Mankind Pharma Ltd.
2474.90
-25.10 (1.00%)
Dr. Reddy's Laboratories Ltd.
1201.00
0.60 (0.05%)
Sun Pharmaceutical Industries FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SUNPHARMA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Daily Research Calls
₹0 AMC for First Year
Dedicated RM Support
+ Free 1st Year AMC